Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Colorcon
McKesson
Farmers Insurance
UBS
Cerilliant
Moodys
Johnson and Johnson
Merck
Federal Trade Commission

Generated: July 22, 2018

DrugPatentWatch Database Preview

Aurobindo Pharma Ltd Company Profile

« Back to Dashboard

What is the competitive landscape for AUROBINDO PHARMA LTD, and what generic and branded alternatives to AUROBINDO PHARMA LTD drugs are available?

AUROBINDO PHARMA LTD has two hundred and fifty-one approved drugs.

There are twenty-eight tentative approvals on AUROBINDO PHARMA LTD drugs.

Summary for Aurobindo Pharma Ltd

Drugs and US Patents for Aurobindo Pharma Ltd

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Aurobindo Pharma Ltd ATHENTIA NEXT levonorgestrel TABLET;ORAL 206867-001 Dec 8, 2015 OTC No No ➤ Try a Free Trial ➤ Try a Free Trial
Aurobindo Pharma Ltd ROSUVASTATIN CALCIUM rosuvastatin calcium TABLET;ORAL 079170-003 Jul 19, 2016 AB RX No No ➤ Try a Free Trial ➤ Try a Free Trial
Aurobindo Pharma Ltd DIVALPROEX SODIUM divalproex sodium TABLET, DELAYED RELEASE;ORAL 090554-001 Apr 21, 2011 AB RX No No ➤ Try a Free Trial ➤ Try a Free Trial
Aurobindo Pharma Ltd METRONIDAZOLE metronidazole TABLET;ORAL 203974-002 May 29, 2015 AB RX No No ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Paragraph IV (Patent) Challenges for AUROBINDO PHARMA LTD drugs
Drugname Dosage Strength Tradename Submissiondate
➤ Subscribe Delayed-release Tablets 20 mg ➤ Subscribe 2015-06-03
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

US Department of Justice
Julphar
Chubb
Moodys
Accenture
Dow
Johnson and Johnson
AstraZeneca
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.